Last 12 months
Inside the activity.
0 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 20 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 31, 2026 Filed Feb 3, 2026 01:07 UTC |
Ganot IlanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 6 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 45,000 Underlying: Common Stock · 15,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary F6 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 60,000 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:07 UTC |
Ganot IlanDirector
|
Exercise / conversionCommon Stock | 15,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034072 · ownership.xml · nonDerivative · entry 1 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 32,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:18 UTC |
Tan KevinCFO & Treasurer
|
Exercise / conversionRestricted Stock Units · Derivative | 33,075 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034089 · ownership.xml · derivative · entry 7 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,225 Underlying: Common Stock · 33,075 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 132,300 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 132,300 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:18 UTC |
Tan KevinCFO & Treasurer
|
Exercise / conversionCommon Stock | 33,075 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034089 · ownership.xml · nonDerivative · entry 2 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,821 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:16 UTC |
Cumbo AlexanderDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 100,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034087 · ownership.xml · derivative · entry 7 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 301,200 Underlying: Common Stock · 100,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 401,600 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 401,600 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:16 UTC |
Cumbo AlexanderDirector · President and CEO
|
Exercise / conversionCommon Stock | 100,400 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034087 · ownership.xml · nonDerivative · entry 2 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 351,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:15 UTC |
Hanrahan JessieChief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 27,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034085 · ownership.xml · derivative · entry 7 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,875 Underlying: Common Stock · 27,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 110,500 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 110,500 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:15 UTC |
Hanrahan JessieChief Regulatory Officer
|
Exercise / conversionCommon Stock | 27,625 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034085 · ownership.xml · nonDerivative · entry 2 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,210 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:14 UTC |
Brooks GabrielChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 28,225 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034083 · ownership.xml · derivative · entry 7 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 84,675 Underlying: Common Stock · 28,225 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F9 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 112,900 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. F9 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 112,900 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:14 UTC |
Brooks GabrielChief Medical Officer
|
Exercise / conversionCommon Stock | 28,225 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034083 · ownership.xml · nonDerivative · entry 2 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:12 UTC |
Howton David TChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 42,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034080 · ownership.xml · derivative · entry 7 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 126,825 Underlying: Common Stock · 42,275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 169,100 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 169,100 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:12 UTC |
Howton David TChief Operating Officer
|
Exercise / conversionCommon Stock | 42,275 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034080 · ownership.xml · nonDerivative · entry 2 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 154,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:09 UTC |
Herzich PaulChief Technology Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 24,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034076 · ownership.xml · derivative · entry 7 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,025 Underlying: Common Stock · 24,675 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F8 · derivative.exercise_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 98,700 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. F8 · derivative.expiration_date: On January 31, 2025 (the "2025 Grant Date"), the reporting person was granted 98,700 RSUs, with 25% of the original number of shares vesting on each anniversary of the 2025 Grant Date until the fourth such anniversary. Read SEC document |
| January 31, 2026 Filed Feb 3, 2026 01:09 UTC |
Herzich PaulChief Technology Officer
|
Exercise / conversionCommon Stock | 24,675 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034076 · ownership.xml · nonDerivative · entry 2 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:07 UTC |
Ganot IlanDirector
|
GrantRestricted Stock Units · Derivative | 35,450 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 5 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 35,450 Underlying: Common Stock · 35,450 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. F5 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:07 UTC |
Ganot IlanDirector
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 70,900 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001193125-26-034072 · ownership.xml · derivative · entry 4 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 70,900 Underlying: Common Stock · 70,900 shares Expires 2036-01-29 F4 · derivative.exercise_date: This option was granted on January 29, 2026 (the "2026 Grant Date") and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:18 UTC |
Tan KevinCFO & Treasurer
|
GrantRestricted Stock Units · Derivative | 93,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034089 · ownership.xml · derivative · entry 6 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 93,500 Underlying: Common Stock · 93,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:18 UTC |
Tan KevinCFO & Treasurer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 187,000 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001193125-26-034089 · ownership.xml · derivative · entry 5 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,000 Underlying: Common Stock · 187,000 shares Expires 2036-01-29 F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:18 UTC |
Tan KevinCFO & Treasurer
|
Exercise / conversionPerformance Stock Units · Derivative | 56,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034089 · ownership.xml · derivative · entry 4 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,646 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:18 UTC |
Tan KevinCFO & Treasurer
|
Exercise / conversionCommon Stock | 56,646 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034089 · ownership.xml · nonDerivative · entry 1 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:16 UTC |
Cumbo AlexanderDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 254,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034087 · ownership.xml · derivative · entry 6 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 254,900 Underlying: Common Stock · 254,900 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:16 UTC |
Cumbo AlexanderDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 509,850 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001193125-26-034087 · ownership.xml · derivative · entry 5 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 509,850 Underlying: Common Stock · 509,850 shares Expires 2036-01-29 F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:16 UTC |
Cumbo AlexanderDirector · President and CEO
|
Exercise / conversionPerformance Stock Units · Derivative | 169,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034087 · ownership.xml · derivative · entry 4 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 169,401 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:16 UTC |
Cumbo AlexanderDirector · President and CEO
|
Exercise / conversionCommon Stock | 169,401 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034087 · ownership.xml · nonDerivative · entry 1 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:15 UTC |
Hanrahan JessieChief Regulatory Officer
|
GrantRestricted Stock Units · Derivative | 95,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034085 · ownership.xml · derivative · entry 6 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:15 UTC |
Hanrahan JessieChief Regulatory Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 190,000 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001193125-26-034085 · ownership.xml · derivative · entry 5 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock · 190,000 shares Expires 2036-01-29 F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:15 UTC |
Hanrahan JessieChief Regulatory Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 54,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034085 · ownership.xml · derivative · entry 4 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:15 UTC |
Hanrahan JessieChief Regulatory Officer
|
Exercise / conversionCommon Stock | 54,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034085 · ownership.xml · nonDerivative · entry 1 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:14 UTC |
Brooks GabrielChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 103,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034083 · ownership.xml · derivative · entry 6 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,750 Underlying: Common Stock · 103,750 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F8 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. F8 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:14 UTC |
Brooks GabrielChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 207,450 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001193125-26-034083 · ownership.xml · derivative · entry 5 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 207,450 Underlying: Common Stock · 207,450 shares Expires 2036-01-29 F7 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:14 UTC |
Brooks GabrielChief Medical Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 58,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034083 · ownership.xml · derivative · entry 4 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,847 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis (the "PSUs"). F6 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. F6 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:14 UTC |
Brooks GabrielChief Medical Officer
|
Exercise / conversionCommon Stock | 58,847 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034083 · ownership.xml · nonDerivative · entry 1 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 96,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis (the "PSUs"). F2 · balance_after: Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on November 28, 2025. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:12 UTC |
Howton David TChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 105,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034080 · ownership.xml · derivative · entry 6 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,100 Underlying: Common Stock · 105,100 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:12 UTC |
Howton David TChief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 210,200 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001193125-26-034080 · ownership.xml · derivative · entry 5 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 210,200 Underlying: Common Stock · 210,200 shares Expires 2036-01-29 F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:12 UTC |
Howton David TChief Operating Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 79,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034080 · ownership.xml · derivative · entry 4 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 79,341 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:12 UTC |
Howton David TChief Operating Officer
|
Exercise / conversionCommon Stock | 79,341 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034080 · ownership.xml · nonDerivative · entry 1 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,249 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:09 UTC |
Herzich PaulChief Technology Officer
|
GrantRestricted Stock Units · Derivative | 85,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034076 · ownership.xml · derivative · entry 6 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSUs") converts to common stock on a one-for-one basis. F7 · derivative.exercise_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. F7 · derivative.expiration_date: The RSUs were granted on the 2026 Grant Date and vest over four years, with 25% of the original number of shares vesting on each anniversary of the 2026 Grant Date until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:09 UTC |
Herzich PaulChief Technology Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $6.60 | $0.00 |
DisclosureSEC source: 0001193125-26-034076 · ownership.xml · derivative · entry 5 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2036-01-29 F6 · derivative.exercise_date: This option was granted on the 2026 Grant Date and vests over four years, with 25% of the original number of shares vesting on the first anniversary of the 2026 Grant Date and 2.0833% of the original number of shares monthly thereafter until the fourth such anniversary. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:09 UTC |
Herzich PaulChief Technology Officer
|
Exercise / conversionPerformance Stock Units · Derivative | 54,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-034076 · ownership.xml · derivative · entry 4 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 54,925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. F5 · derivative.exercise_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. F5 · derivative.expiration_date: The PSUs were granted on June 11, 2024 and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"), subject to the grantee's continued service with the Company (the "Approval Conditions"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the first Performance Milestone was determined to be met on January 29, 2026 (the "2026 Grant Date") resulting in the vesting of the PSUs as to 25% of the underlying shares. Read SEC document |
| January 29, 2026 Filed Feb 3, 2026 01:09 UTC |
Herzich PaulChief Technology Officer
|
Exercise / conversionCommon Stock | 54,925 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-034076 · ownership.xml · nonDerivative · entry 1 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 81,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance stock unit ("PSUs") converts to common stock on a one-for-one basis. Read SEC document |
| January 29, 2026 Filed Apr 21, 2026 20:05 UTC |
Howton David TChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 79,341 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-166736 · ownership.xml · derivative · entry 1 Howton David T · CIK 0001529297 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,341 Underlying: Common Stock · 79,341 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. Read SEC document |
| January 29, 2026 Filed Apr 21, 2026 20:05 UTC |
Brooks GabrielChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 58,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-166734 · ownership.xml · derivative · entry 1 Brooks Gabriel · CIK 0001997809 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,847 Underlying: Common Stock · 58,847 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. Read SEC document |
| January 29, 2026 Filed Apr 21, 2026 20:05 UTC |
Cumbo AlexanderDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 169,401 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-166735 · ownership.xml · derivative · entry 1 Cumbo Alexander · CIK 0001685994 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 169,401 Underlying: Common Stock · 169,401 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. Read SEC document |
| January 29, 2026 Filed Apr 21, 2026 20:05 UTC |
Herzich PaulChief Technology Officer
|
GrantRestricted Stock Units · Derivative | 54,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-166733 · ownership.xml · derivative · entry 1 Herzich Paul · CIK 0001954991 · Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,925 Underlying: Common Stock · 54,925 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. Read SEC document |
| January 29, 2026 Filed Apr 21, 2026 20:05 UTC |
Tan KevinCFO & Treasurer
|
GrantRestricted Stock Units · Derivative | 56,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-166732 · ownership.xml · derivative · entry 1 Tan Kevin · CIK 0001884056 · CFO & Treasurer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,647 Underlying: Common Stock · 56,647 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. Read SEC document |
| January 29, 2026 Filed Apr 21, 2026 20:05 UTC |
Hanrahan JessieChief Regulatory Officer
|
GrantRestricted Stock Units · Derivative | 54,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-166731 · ownership.xml · derivative · entry 1 Hanrahan Jessie · CIK 0001954826 · Chief Regulatory Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,925 Underlying: Common Stock · 54,925 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs"). F2 · derivative.exercise_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. F2 · derivative.expiration_date: Performance stock units ("PSUs") were granted on June 11, 2024, and provide for the vesting of 25% of the target number of underlying RSUs granted upon the achievement of each of four independent performance milestones predetermined by the Board ("Performance Milestones"). The Performance Milestones are tied to the achievement of certain business objectives, as certified by the Board on specified evaluation dates, and are non-market and non-financial in nature. The performance criteria specified for the second Performance Milestone was determined by the Board to be met on January 29, 2026, and the shares related to such Performance Milestone will vest subject to the grantee's continued service with the Company on the Evaluation Date, which is anticipated to occur in the first quarter of 2027. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 21:05 UTC |
Ganot IlanDirector
|
SaleCommon Stock | 191 | $6.59 | $1,258.69 |
DisclosureSEC source: 0001193125-26-031765 · ownership.xml · nonDerivative · entry 2 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 17,476 F2 · kind: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot. F2 · shares: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units pursuant to a durable automatic sales instruction letter adopted by Ms. Ganot on September 25, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Ms. Ganot. Read SEC document |
| January 27, 2026 Filed Jan 30, 2026 21:05 UTC |
Ganot IlanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,884 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-031765 · ownership.xml · derivative · entry 6 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,884 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. F6 · derivative.expiration_date: On the Grant Date, the reporting person was granted 15,533 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. Read SEC document |
| January 27, 2026 Filed Jan 30, 2026 21:05 UTC |
Ganot IlanDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 389 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-031765 · ownership.xml · derivative · entry 5 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Wife Disclosed balance after: 0 Underlying: Common Stock · 389 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F5 · derivative.exercise_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. F5 · derivative.expiration_date: On January 27, 2022 (the "Grant Date") Ms. Ganot was granted 1,553 restricted stock units, vesting in four equal installments on the anniversary of the Grant Date. Read SEC document |
| January 27, 2026 Filed Jan 30, 2026 21:05 UTC |
Ganot IlanDirector
|
Exercise / conversionCommon Stock | 3,884 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-031765 · ownership.xml · nonDerivative · entry 3 Ganot Ilan · CIK 0001727460 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 99,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F3 · ownership.direct: Represents 95,255 shares held by Mr. Ganot as an individual, and 4,042 shares held by Mr. Ganot and Annie Ganot as joint tenants with right of survivorship. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.